Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit
EAS 2025: Πώς να αναγνωρίσετε τους ασθενείς με πολύ υψηλό κίνδυνο καρδιαγγειακών επεισοδίων

EAS 2025: Πώς να αναγνωρίσετε τους ασθενείς με πολύ υψηλό κίνδυνο καρδιαγγειακών επεισοδίων

Bedienungsanleitung zum Sanofi-Webshop

Bedienungsanleitung zum Sanofi-Webshop

Respiratory 2025: TSANZSRS symposium

Event one: What next for COPD?
Biomarkers, phenotypes, endotypes, and targeted treatment

Recorded on 24 March at TSANZSRS 2025 ASM

EAS 2025 : Αναγνώριση και Διαχείριση του ασθενούς πριν από το Οξύ Στεφανιαίο Σύμβαμα

EAS 2025 : Αναγνώριση και Διαχείριση του ασθενούς πριν από το Οξύ Στεφανιαίο Σύμβαμα

Videoreportáž EHA Milano

Videoreportáž EHA Milano

Webinar On-Demand: Optimizing the Type 2 Diabetes Patient Journey with Fixed-Ratio Combinations

Webinar On-Demand: Optimizing the Type 2 Diabetes Patient Journey with Fixed-Ratio Combinations

Sanofi-sponsored symposium originally presented at SEMDSA 2025, now available on-demand. In this engaging session, leading experts delve into the critical decision points along the Type 2 Diabetes patient journey and the evolving role of Fixed-Ratio Combination (FRC) therapies. Explore real-world patient challenges and gain a deeper understanding of how FRCs can simplify treatment, improve adherence, and support better outcomes. The session also features a comparative analysis of the latest efficacy and safety data on iGlarLixi (insulin glargine/lixisenatide) versus iDegAsp (insulin degludec/aspart) in non-Asian populations—shedding light on practical considerations for clinical use.

Záznam ze sympozia -

Záznam ze sympozia - "Příhoda není náhoda, nečekejme na ni"

Záznam ze sympozia -

Záznam ze sympozia - "Proč nevyužíváme potenciál hypolipidemické léčby ani u rizikových pacientů?"

Ukryty wpływ skumulowanego upośledzenia przebiegu życia (CLCI) w dermatologii: Wprowadzenie

Ukryty wpływ skumulowanego upośledzenia przebiegu życia (CLCI) w dermatologii: Wprowadzenie

Personalizing Antiplatelet Therapy: Insights for High-Risk PCI Patients

Personalizing Antiplatelet Therapy: Insights for High-Risk PCI Patients

Personalizing Antiplatelet Therapy: Insights for High-Risk PCI Patients

Personalizing Antiplatelet Therapy: Insights for High-Risk PCI Patients

From Risk to Recurrence: Clinical Truths from the RIETE Registry on VTE Outcomes

From Risk to Recurrence: Clinical Truths from the RIETE Registry on VTE Outcomes